Search

Your search keyword '"Di Napoli, M"' showing total 514 results

Search Constraints

Start Over You searched for: Author "Di Napoli, M" Remove constraint Author: "Di Napoli, M"
Sorry, I don't understand your search. ×
514 results on '"Di Napoli, M"'

Search Results

1. Management of Metastatic Disease in Campania (MAMETIC): An Observational Multicenter Retrospective and Prospective Trial on Palliative Radiotherapy in an Italian Region. Study Protocol

4. Inadequate PROs and HRQoL reporting in phase III advanced genitourinary tumors RCTs

5. PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives

8. Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

11. 52P Real-world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group

13. Signs and symptoms of COVID-19 in patients with multiple sclerosis

16. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

17. Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel

18. Signs and symptoms of COVID-19 in patients with multiple sclerosis

19. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

21. The Italian multiple sclerosis register

22. Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies

26. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

27. Regular physical activity postpones age of occurrence of first-ever stroke and improves long-term outcomes.

28. Slow-moving landslide risk assessment combining Machine Learning and InSAR techniques

29. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

31. COVID-19 pandemic and burden of non-communicable diseases: An ecological study on data of 185 countries.

32. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE)

33. Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results

34. Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

35. COVID-19 Pandemic and Burden of Non-Communicable Diseases: An Ecological Study on Data of 185 Countries

36. Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

37. Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel

38. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

40. LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study

41. Geomorphology of Cinque Terre National Park (Italy).

42. pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics

43. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data

45. Diagnostic accuracy of Hybrid Capture 2 test: Results obtained from internal quality control

46. Monomeric C-reactive protein and cerebral hemorrhage: From bench to bedside

47. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.

48. Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinumbased chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

49. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type

50. Long-term tolerability of olaparib tablets as maintenance therapy for platinum-sensitive relapsed ovarian cancer (PSR OC): Phase III SOLO2 trial

Catalog

Books, media, physical & digital resources